Exclusive

Publication

Byline

Barometers trade in negative terrain; consumer durables shares decline

Mumbai, Nov. 7 -- The key equity benchmarks continued to trade with significant losses in morning trade, supported by weak global cues. Investors sentiment was further dampened by FII selling, led to ... Read More


Woman says she rejected Zohran Mamdani on Hinge over his height; internet calls it 'fumble of the century'

India, Nov. 7 -- Zohran Mamdani, the mayor-elect of New York City, has become one of the most-talked-about personalities on the internet. Amid discussions surrounding the Democratic Socialist's life, ... Read More


Sri Lanka records over 1.9 mln tourist arrivals so far in 2025

Sri Lanka, Nov. 7 -- The Sri Lanka Tourism Development Authority (SLTDA) has announced that the total number of foreign tourists who have visited the country so far in 2025 has exceeded 1.9 million. ... Read More


COP30: Indonesia pledges stronger climate action at leader summit

Belem, Brazil, Nov. 7 -- Indonesia reaffirmed its commitment to strengthening national climate action during the Belem Leader Summit in Brazil, according to President Prabowo Subianto's Special Envoy ... Read More


Two years on from EU deal, violence against migrants in Tunisia remains rife

France, Nov. 7 -- Tunisia's migration policy is under scrutiny two years on from a deal with the European Union intended to discourage illegal migration from the North African country, and from a "rep... Read More


Bengaluru real estate: Techies become cautious about homeownership amid layoffs and AI disruption

India, Nov. 7 -- As Bengaluru's once-thriving IT workforce grapples with layoffs, the rise of Artificial Intelligence, and weakening global demand, the dream of homeownership is being replaced by caut... Read More


Clinical Trial: Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225439) titled 'Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relap... Read More


Clinical Trial: Shifting Options Study

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225595) titled 'Shifting Options Study' on Nov. 19, 2024. Brief Summary: The goal of Shifting Options is to... Read More


Clinical Trial: The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Energy, and Cognition

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225608) titled 'The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Ener... Read More


Clinical Trial: Personalizing Financial Incentives

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225426) titled 'Personalizing Financial Incentives' on Nov. 04. Brief Summary: The purpose of this study is... Read More